These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 7048789)
1. [Pharmacology of prostacyclin and prostacyclin-like compounds]. Lakin KM; Baluda VP; Makarov VA Vestn Akad Med Nauk SSSR; 1982; (5):81-91. PubMed ID: 7048789 [No Abstract] [Full Text] [Related]
2. Prostacyclin in physiology and pathophysiology. Vane JR; Bunting S; Moncada S Int Rev Exp Pathol; 1982; 23():161-207. PubMed ID: 6806207 [No Abstract] [Full Text] [Related]
3. The role of prostacyclin and thromboxane A2 in the regulation of platelet behaviour. Moncada S Mater Med Pol; 1980; 12(3):207-12. PubMed ID: 7019591 [No Abstract] [Full Text] [Related]
4. [Role of prostacyclin and thromboxane A2 in the cardiovascular system]. Ismailov ShI; Val'dman AV Kardiologiia; 1981 Mar; 21(3):111-6. PubMed ID: 7014974 [No Abstract] [Full Text] [Related]
5. [Platelet aggregation and endogenous prostaglandins and thromboxane (author's transl)]. Katori M No Shinkei Geka; 1980 Aug; 8(8):717-22. PubMed ID: 6999371 [No Abstract] [Full Text] [Related]
6. Prostacyclin in the cardiovascular system. Moncada S; Vane JR Adv Prostaglandin Thromboxane Res; 1980; 6():43-60. PubMed ID: 6992536 [No Abstract] [Full Text] [Related]
7. Thromboxane and prostacyclin: implications for function and disease of the vasculature. McGiff JC Adv Intern Med; 1980; 25():199-216. PubMed ID: 6987841 [No Abstract] [Full Text] [Related]
8. [Thromboxane A2 antagonist, prostacyclin (PGI2)--its in vivo secretion and action mechanism]. Okuma M Nihon Rinsho; 1978 Dec; 36(12):3830-5. PubMed ID: 372621 [No Abstract] [Full Text] [Related]
9. [Prostacyclin as a protective factor for blood vessels]. Leithner C; Sinzinger H; Silberbauer K Fortschr Med; 1980 Dec; 98(47-48):1845-9. PubMed ID: 7011923 [TBL] [Abstract][Full Text] [Related]
11. [Effects of prostaglandins and blockaders]. Tajima K; Takata Y; Kanda S; Kuriyama H Nihon Rinsho; 1979; 37(7):2859-65. PubMed ID: 393866 [No Abstract] [Full Text] [Related]
12. Prostaglandins and prostaglandin inhibitors in ischemic heart disease. Pitt B; Shea MJ; Romson JL; Lucchesi BR Ann Intern Med; 1983 Jul; 99(1):83-92. PubMed ID: 6407379 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacological action on the thromboxane and prostacyclin balance in the body]. Lakin KM; Makarov VA; Novikova NV; Tret'iak VM; Rukazenkov IuE Farmakol Toksikol; 1984; 47(2):67-79. PubMed ID: 6425078 [No Abstract] [Full Text] [Related]
14. [Function of prostaglandins in platelet aggregation]. Sun QW Sheng Li Ke Xue Jin Zhan; 1980 Feb; 11(2):137-42. PubMed ID: 7001620 [No Abstract] [Full Text] [Related]
15. 11- and 15-deoxy-carboprostacyclins: hypothetic prostacyclin antagonists. Mongelli N; Magni O; Gandolfi C; Grossoni M; Ceserani R Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():281-5. PubMed ID: 6221538 [No Abstract] [Full Text] [Related]
16. The anti-thrombotic effects of prostacyclin. Vane JR; Moncada S Acta Med Scand Suppl; 1980; 642():11-22. PubMed ID: 7006326 [No Abstract] [Full Text] [Related]
17. [Platelet aggregation, thrombosis formation and prostaglandins]. Higashihara M; Kume S Nihon Rinsho; 1985 Mar; 43(3):555-62. PubMed ID: 3159919 [No Abstract] [Full Text] [Related]
18. Prostacyclin-synthesis stimulating plasma factor and platelet sensitivity in preeclampsia. Dadak C; Kefalides A; Sinzinger H Biol Res Pregnancy Perinatol; 1985; 6(2):65-9. PubMed ID: 3893552 [TBL] [Abstract][Full Text] [Related]
19. Prostanoids in platelet-vascular interactions. Martin TJ; Smith IL; Nolan RD; Dusting GJ Am J Cardiol; 1983 Jul; 52(2):22A-27A. PubMed ID: 6346850 [TBL] [Abstract][Full Text] [Related]
20. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Moncada S; Korbut R Lancet; 1978 Jun; 1(8077):1286-9. PubMed ID: 78050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]